Literature DB >> 1816727

Tokishakuyakusan stimulates progesterone and estradiol-17 beta production by rat granulosa cells and progesterone, testosterone and estradiol-17 beta by the residual portion of the follicle in vitro.

S Usuki1.   

Abstract

To examine the possible effects of Tokishakuyakusan (TS) on steroidogenesis by preovulatory follicles at the cell level, the expressed granulosa cells and remaining portion of follicles from pregnant mare's serum gonadotropin (PMS)-treated immature rats were incubated in vitro with increasing concentrations of TS for 3 h. TS significantly stimulated progesterone and estradiol-17 b production, with a predominant stimulation of progesterone, by the expressed granulosa cells, while testosterone production was not stimulated. In the remaining portion of the follicle, TS also significantly stimulated progesterone, testosterone and estradiol-17 b production. Similar to the effect produced by granulosa cells, the stimulatory effect of TS was stronger on progesterone than on testosterone and estradiol-17 b production. These results suggest that TS has a potent, direct stimulatory effect on steroidogenesis, especially progesterone production, by constituent tissue compartments of rat preovulatory follicles in vitro.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1816727     DOI: 10.1142/S0192415X91000223

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  2 in total

1.  Analysis of mutations of two Gitelman syndrome family SLC12A3 genes and proposed treatments using Chinese medicine.

Authors:  Jie-Wei Luo; Xiao-Rong Meng; Xiao Yang; Ji-Xing Liang; Fu-Yuan Hong; Xing-Yu Zheng; Wei-Hua Li
Journal:  Chin J Integr Med       Date:  2016-01-29       Impact factor: 1.978

2.  Danggui-Shaoyao-San Improves Learning and Memory in Female SAMP8 via Modulation of Estradiol.

Authors:  Yan Huang; Zeng-Yao Hu; Hui Yuan; Lei Shu; Gang Liu; Shan-Yi Qiao; Lei Sun; Wen-Xia Zhou; Yong-Xiang Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-16       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.